INTERNATIONAL PATENT: ASTELLAS PHARMA INC., アステラス製薬株式会社 FILES APPLICATION FOR "ANTIBODY-DRUG CONJUGATE CONTAINING HETEROCYCLIC COMPOUND HAVING ACTIVITY OF INDUCING DECOMPOSITION OF G12D MUTANT KRAS PROTEIN"

GENEVA, March 25 -- ASTELLAS PHARMA INC. (5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo1038411), アステラス製薬株式会社 (東京都中央区日本橋本町二丁目５番１号) filed a patent application (PCT/JP2024/032664) for "ANTIBODY-DRUG CONJUGATE CONTAINING HETEROCYCLIC COMPOUND HAVING ACTIVITY OF INDUCING DECOMPOSITION OF G12D MUTANT KRAS PROTEIN" on Sep 12, 2024. With publication no. WO/2025/058008, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system...